Omni Bio Pharmaceutical, Inc. announced the appointment of Bruce E. Schneider, PhD, as its Chief Executive Officer, effective January 1, 2013. Dr. Schneider will also become a member of the company's board of directors. Dr. Schneider has recently served as an executive advisor to several large and small pharmaceutical companies, including an extensive role with Pfizer where he was engaged to facilitate strategic planning and decision-making for its early drug development pipeline.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +66.67% | +233.33% |
2016 | Omni Bio Pharmaceutical, Inc. cancelled the transaction announced on March 16, 2015 | CI |
2015 | Omni Bio Pharmaceutical, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+233.33% | 50.06K | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- OMBP Stock
- News Omni Bio Pharmaceutical, Inc.
- Omni Bio Pharmaceutical, Inc. Appoints Bruce E. Schneider as Chief Executive Officer, Effective January 1, 2013